The dangerous mythology of dopamine marketing
Dopamine is not the enemy. Reducing human choice to a chemical hit is a myth that weakens strategy and erodes trust.
Quick brief
- Marketing borrowed a neurotransmitter and turned it into a sales pitch.
- Dopamine is implicated in motivation and learning in context, not in isolated purchase triggers.
- Strategies built on the myth over-invest in stimulation and under-invest in meaning.
- Audit any tactic justified by 'dopamine' and ask what it teaches the customer.
What we know
- Dopamine is a neuromodulator involved in motivation, learning and movement.
- It operates in context, not in isolation.
- Attention, meaning and memory shape dopaminergic responses.
- Sustained behaviour change requires narrative and identity alignment.
What marketers often claim
- "Dopamine drives every purchase."
- "We can hack dopamine for instant results."
- "More stimulation always means more engagement."
- "Buyers are irrational, so logic doesn't matter."
The myth survives because it sells workshops. It is easier to promise a chemical lever than to build a story people can repeat.
The bottom line
Brands that build stories people believe earn trust, preference and pricing power. Brands that chase stimulation rent attention at rising cost.
Audit your stories. Do they teach, move, and make it easy to decide? If a tactic only startles, retire it.
Sources
- Nature Reviews Neuroscience — Understanding dopamine (1 Jan 2013)
- Journal of Consumer Psychology — The myth of dopamine as a marketer's magic bullet (1 Jan 2020)